Background: No compelling evidence is available about surveillance and follow-up of patients with testicular germ cell tumour (TGCT). Methods: In the light of the best clinical evidence, the Italian Germ cell cancer Group (IGG) and the Associazione Italiana di Oncologia Medica (AIOM) set up a multidisciplinary national consensus conference, involving 42 leading experts and 3 TGCT survivors. A minimum of 50% of votes was required in order to achieve a consensus recommendation on 29 questions. Results: Recommendations have been summarized in three tables, divided by stage I seminoma, stage I nonseminoma and the advanced disease, which may be useful for clinicians to appropriately choose the clinical investigation and its timing during the surveillance and follow-up of TGCT patients based on an accurate estimation of their risk of disease relapse. Conclusions: The IGG-AIOM consensus recommendations may help clinicians to choose appropriate clinical investigations for the surveillance and follow-up of TGCT patients.
Recommendations for Surveillance and Follow-Up of Men With Testicular Germ Cell Tumors: A Multidisciplinary Consensus Conference by the Italian Germ Cell Cancer Group and the Associazione Italiana Di Oncologia Medica / Banna, G.L., Nicolai, N., Palmieri, G., Ottaviano, M., Balzarini, L., Barone, D., Basso, U., Bavila, A., Bertoni, F., Calliada, F., Cai, T., Carrafiello, G., Condello, C., Da Pozzo, L., Di Nardo, D., Fornarini, G., Prayer Galetti, T., Garolla, A., Giannatempo, P., Guerra, L., et al.. - In: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. - ISSN 1040-8428. - 2019/137:(2019), pp. 154-164. [10.1016/j.critrevonc.2019.03.006]
Recommendations for Surveillance and Follow-Up of Men With Testicular Germ Cell Tumors: A Multidisciplinary Consensus Conference by the Italian Germ Cell Cancer Group and the Associazione Italiana Di Oncologia Medica
Cai, Tommaso;
2019-01-01
Abstract
Background: No compelling evidence is available about surveillance and follow-up of patients with testicular germ cell tumour (TGCT). Methods: In the light of the best clinical evidence, the Italian Germ cell cancer Group (IGG) and the Associazione Italiana di Oncologia Medica (AIOM) set up a multidisciplinary national consensus conference, involving 42 leading experts and 3 TGCT survivors. A minimum of 50% of votes was required in order to achieve a consensus recommendation on 29 questions. Results: Recommendations have been summarized in three tables, divided by stage I seminoma, stage I nonseminoma and the advanced disease, which may be useful for clinicians to appropriately choose the clinical investigation and its timing during the surveillance and follow-up of TGCT patients based on an accurate estimation of their risk of disease relapse. Conclusions: The IGG-AIOM consensus recommendations may help clinicians to choose appropriate clinical investigations for the surveillance and follow-up of TGCT patients.| File | Dimensione | Formato | |
|---|---|---|---|
|
CRoncology_2019.pdf
Solo gestori archivio
Tipologia:
Versione editoriale (Publisher’s layout)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
219.51 kB
Formato
Adobe PDF
|
219.51 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione



